As a pharmacy doctor, you will hear buzz about new injectable Mounjaro (tirzepatide), the first "twincretin" for type 2 diabetes . Think of Mounjaro as similar to a glucagon-like peptide-1 (GLP-1) agonist, BUT it’s also a glucose-dependent insulinotropic polypeptide (GIP) agonist. More twincretins are in the works. GL…
قراءة المزيدAs a nutrition support pharmacist, you will hear more about using Saxenda for weight loss in adolescents 12 and up, not just in adults. Saxenda will be the first GLP-1 agonist for obesity, that in addition to stimulating insulin release and inhibiting glucagon secretion, slows gastric emptying and increases satiety after eating, (see our Note about Saxenda for weigh…
قراءة المزيدOn WORLD DIABETES DAY (14 November), the question is increasing about what is the best diet to improve blood glucose level. Medical nutrition therapy plays an important role in the management of diabetes, it has a significant impact on T2DM patients. Counseling and education sessions for development of an individualized eating plan according to the metabolic needs of…
قراءة المزيدPatients with type 2 diabetes (T2D) constitute approximately 90%-95% of all patients with diabetes worldwide. In 2013, 382 million adults were diagnosed with diabetes worldwide. This number is expected to grow to 592 million in 2035. About 1 in 3 adults and 1 in 5 adolescents in the U.S. have prediabetes, but most are unaware. Prediabetes is the term used for ind…
قراءة المزيدNPS | Notes in Pharmacy Specialties is a free, open-access, peer-reviewed site focused on pharmacy practice. Articles are immediately accessible, covering clinical pharmacy, pharmaceutical care, health promotion, informatics, and more.
Egypt - Phone: (+20)1210274589
Gmail: abdelwahabward@gmail.com
Social Plugin